Table 4.
Cost-effectiveness, Societal Perspective
| Strategy | Mean Costs, $ | Mean Effects, QALMs | Incremental Costs, $ | Incremental Effects, QALMs | ICER†, $/QALM gained |
|---|---|---|---|---|---|
| Community pharmacist-initiated | 78.70 (54.27; 108.25) | 0.75232 (0.51506; 0.92437) | – | – | – |
| Family physician-initiated | 239.43 (162.36; 327.39) | 0.75236 (0.51555; 0.92461) | 161.09 (80.29; 255.07) | 0.00004 (−0.00685; 0.00709) | 4,027,250 |
| Emergency physician-initiated | 609.78 (382.65; 894.90) | 0.75239 (0.51676; 0.93418) | – | – | Extended dominance |
†Sequential analysis